Table 2.
Details of supportive therapy
| ACEi/ARB (%) | 81 (84.4) / 15 (15.6) |
|---|---|
| Dose of ACEi/ARB achieved (% of maximum labeled dose): | |
| 100% | 59 (61.5) |
| 75% | 10 (10.4) |
| 50% | 21 (21.9) |
| < 50% | 6 (6.3) |
| Requirement for additional antihypertensives (%) | 54 (56.3) |
| Treatment for dyslipidemia (%) | 26 (27.1) |
| Treatment for hyperuricemia (%) | 44 (45.8) |
ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker.